永安药业：关于子公司湖北凌安科技有限公司完成工商变更登记暨对外投资的进展公告

Core Points - Yong'an Pharmaceutical announced the acquisition of a 49.20% stake in its subsidiary Hubei Ling'an Technology Co., Ltd. for 27 million yuan, aiming to gain 100% ownership of the company [2] Group 1 - The board of directors approved the investment proposal during the ninth temporary meeting of the seventh board session, scheduled for September 24, 2025 [2] - The acquisition will not change the scope of the company's consolidated financial statements [2] - The company has already made the first payment to the sellers as per the share transfer agreement [2] Group 2 - Hubei Ling'an Technology has completed the necessary business registration changes and received a new business license from the market supervision administration [2]